Flexion Therapeutics to Report First-Quarter 2021 Financial Results on May 12, 2021
May 05 2021 - 4:30PM
Flexion Therapeutics, Inc. (Nasdaq:FLXN) today announced that it
will report its first-quarter 2021 financial results after the
close of the U.S. financial markets on Wednesday, May 12, 2021.
A live webcast of the conference call can be accessed through
the “Investors” tab on the Flexion Therapeutics website, and a
replay will be available online after the call. For those planning
to ask a question, the dial-in number for the conference call is
855-770-0022 for domestic participants and 908-982-4677 for
international participants, with Conference ID # 9786283. Please
dial in at least 15 minutes in advance to ensure a timely
connection to the call.
About Flexion TherapeuticsFlexion
Therapeutics (Nasdaq:FLXN) is a biopharmaceutical company
focused on the development and commercialization of novel, local
therapies for the treatment of patients with musculoskeletal
conditions, beginning with osteoarthritis, the most common form of
arthritis. The company's core values are focus, ingenuity,
tenacity, transparency and fun. Please visit
flexiontherapeutics.com.
Contact:
Scott YoungVice President, Corporate Communications &
Investor RelationsT: 781-305-7194syoung@flexiontherapeutics.com
Flexion Therapeutics (NASDAQ:FLXN)
Historical Stock Chart
From Apr 2024 to May 2024
Flexion Therapeutics (NASDAQ:FLXN)
Historical Stock Chart
From May 2023 to May 2024